The conversion charts between medications can help, but always verify with your provider
Values and Preferences The kidney and cardiovascular benefits of additional therapy with RAASi, SGLT2i, GLP1-RA, and nsMRA, including additional testing and visits, must be balanced against the need for additional medications, as well as associated lab testing for individuals with residual risk due to persistent nephropathy with A3 albuminuria
While GHRP-2 primarily stimulates growth hormone release, which is known to aid fat metabolism and promote lipolysis (fat breakdown), it also significantly increases appetite and food intake
However, individual response depends on baseline biomarker status, genetic predispositions, and overall metabolic healthfactors that warrant personalized assessment rather than a generalized approach